Advanced Search
Contact | Corporate | Help

Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma

Sponsors:
  • New York University School of Medicine
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Brain Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Temozolomide, bevacizumab, lithium, radiation
Enrollment:
54

Additional information about NCT01105702.


SourceSolution © 2008-2012